KAM
ABEO icon

Kavi Asset Management’s Abeona Therapeutics ABEO Stock Holding History

Kavi Asset Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,508
Closed -$1.25M – 26
2018
Q1 		$1.25M Sell
3,508
-5,076
-59% -$1.89M 0.45% 33
2017
Q4 		$3.4M Sell
8,584
-1,832
-18% -$758K 2.35% 19
2017
Q3 		$4.44M Sell
10,416
-4,208
-29% -$1.13M 2.13% 22
2017
Q2 		$2.34M Hold
14,624
– – 1.24% 23
2017
Q1 		$1.83M Hold
14,624
– – 1.27% 27
2016
Q4 		$1.77M Buy
14,624
+12,092
+478% +$1.89M 1.3% 22
2016
Q3 		$380K Buy
+2,532
New +$248K 0.33% 24

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kavi Asset Management's ABEO Position: Q2 2018 in Review

Kavi Asset Management sold out of Abeona Therapeutics (ABEO) in Q2 2018, closing a stake of 3,508 shares — an estimated $1.25M sold.

Kavi Asset Management first reported a position in ABEO in Q3 2016 and held it in 7 quarters. The position peaked at $4.44M in Q3 2017. 92 funds tracked by Wall St. Rank hold ABEO as of Q2 2018.

  • Kavi Asset Management reported no remaining Abeona Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Kavi Asset Management sold 3,508 Abeona Therapeutics shares in Q2 2018, an estimated $1.25M.
  • Kavi Asset Management first reported a position in Abeona Therapeutics in Q3 2016 and held it in 7 quarters.
  • Kavi Asset Management's Abeona Therapeutics position peaked at $4.44M in Q3 2017.
  • 92 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2018.

Based on Kavi Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.